Alyssa Pham, DPM
Foot & Ankle Surgery · Fort Myers, FLNPI 1316435845
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (56.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Arthrex accounts for 64.4% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2022 at $8,205 and has fallen 97.7% since, to $192 in 2025.
Across 88 payments — averaging $144.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$8K
- Acumed LLC$2K
- Medline Industries LP$991
- MVP Orthopedics Inc$467
- Biotissue Holdings Inc.$203
- Integra Lifesciences Corporation$143
- plus $907 from 17 others
What the payments were for
- Travel & lodging$2,10117%
- Food & beverage$3,39727%
- Education$7,20057%
- Gifts$220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 40 | $8,186 |
| Acumed LLC | 8 | $1,822 |
| Medline Industries LP | 6 | $991 |
| MVP Orthopedics Inc | 4 | $467 |
| Biotissue Holdings Inc. | 3 | $203 |
| Integra Lifesciences Corporation | 2 | $143 |
| AbbVie | 2 | $140 |
| Treace Medical Concepts, Inc. | 3 | $126 |
| Organogenesis Inc. | 1 | $119 |
| Medtronic | 1 | $97 |
| Alafair Biosciences, Inc. | 1 | $66 |
| Stryker | 2 | $64 |
| Amgen | 3 | $56 |
| Smith+Nephew | 2 | $50 |
| Bioventus LLC | 2 | $35 |
| ANI Pharmaceuticals, Inc. | 1 | $26 |
| KCI USA, Inc. | 1 | $24 |
| Abbott | 1 | $21 |
| Fidia Pharma USA Inc. | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Averitas Pharma Inc. | 1 | $17 |
| Linvatec Corporation | 1 | $16 |
| Medinc Of Texas | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,720 in reported general payments places this provider in the 80th percentile of 850 foot & ankle surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 12 | $10,399 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 85 | $1,971 |
| Clobetasol Propionate | 25 | $1,419 |
| Ciclopirox | 62 | $1,128 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 17 | $807 |
| Ketoconazole | 12 | $449 |
| Terbinafine Hcl | 18 | $156 |
| Meloxicam | 28 | $156 |
| Gabapentin | 19 | $82 |
| Clindamycin Hcl | 11 | $69 |
| Cephalexin | 18 | $65 |
| Ciprofloxacin Hcl | 11 | $58 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Fort Myers
- Andrew BelisFort Myers$206K
- Chad SimmonsFort Myers$60K
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Thomas RoukisOrlando$1M
- Craig BreslauerStuart$971K
- Bradley LammWest Palm Beach$861K
- Amber ShaneOrlando$830K
- Jonathan BlumKissimmee$785K
- Mario CalaHialeah$541K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.